Similar articles

• Physiological approaches to increase biocompatibility of peritoneal dialysis.

  Breborowicz A, Oreopoulos DG. Breborowicz A, et al. Perit Dial Int. 1995;15(7 Suppl):S76-85; discussion S85-6. Perit Dial Int. 1995. PMID: 8555331 Review. No abstract available.
• Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).

  Davies SJ, Yewdall VM, Ogg CS, Cameron JS. Davies SJ, et al. Perit Dial Int. 1990;10(2):135-40. Perit Dial Int. 1990. PMID: 2085598
• Fluid and solute transport across the peritoneum during continuous ambulatory peritoneal dialysis (CAPD).

  Krediet RT, Arisz L. Krediet RT, et al. Perit Dial Int. 1989;9(1):15-25. Perit Dial Int. 1989. PMID: 2488175 No abstract available.
• Peritoneal host defense mechanisms in peritoneal dialysis.

  Holmes CJ. Holmes CJ. Kidney Int Suppl. 1994 Dec;48:S58-70. Kidney Int Suppl. 1994. PMID: 7700043 Review. No abstract available.
• Impact of peritoneal dialysis solutions on peritoneal immune defense.

  Jörres A, Topley N, Witowski J, Liberek T, Gahl GM. Jörres A, et al. Perit Dial Int. 1993;13 Suppl 2:S291-4. Perit Dial Int. 1993. PMID: 8399591